CHIARANTINI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 12.184
EU - Europa 7.860
AS - Asia 4.638
SA - Sud America 464
Continente sconosciuto - Info sul continente non disponibili 172
AF - Africa 57
OC - Oceania 25
Totale 25.400
Nazione #
US - Stati Uniti d'America 12.040
GB - Regno Unito 2.677
CN - Cina 2.268
IT - Italia 1.382
SG - Singapore 1.337
UA - Ucraina 1.063
SE - Svezia 623
RU - Federazione Russa 557
FI - Finlandia 464
DE - Germania 429
TR - Turchia 392
BR - Brasile 333
VN - Vietnam 224
FR - Francia 222
IE - Irlanda 214
IN - India 91
CA - Canada 88
BD - Bangladesh 53
AR - Argentina 47
HK - Hong Kong 45
KR - Corea 44
PL - Polonia 40
ES - Italia 38
BE - Belgio 33
NL - Olanda 32
MX - Messico 28
JP - Giappone 27
EC - Ecuador 26
AU - Australia 20
CO - Colombia 17
IQ - Iraq 15
SA - Arabia Saudita 15
IR - Iran 14
PK - Pakistan 13
AE - Emirati Arabi Uniti 12
ZA - Sudafrica 12
AT - Austria 11
CL - Cile 11
MA - Marocco 11
EU - Europa 10
ID - Indonesia 10
PY - Paraguay 10
UZ - Uzbekistan 9
CH - Svizzera 8
EE - Estonia 8
TG - Togo 8
VE - Venezuela 8
AZ - Azerbaigian 7
KE - Kenya 7
KZ - Kazakistan 7
BO - Bolivia 6
HN - Honduras 6
JO - Giordania 6
LT - Lituania 6
CZ - Repubblica Ceca 5
IL - Israele 5
NZ - Nuova Zelanda 5
PA - Panama 5
PE - Perù 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
CR - Costa Rica 4
DK - Danimarca 4
EG - Egitto 4
KG - Kirghizistan 4
LA - Repubblica Popolare Democratica del Laos 4
LU - Lussemburgo 4
MY - Malesia 4
PH - Filippine 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GR - Grecia 3
HU - Ungheria 3
LV - Lettonia 3
NP - Nepal 3
OM - Oman 3
PT - Portogallo 3
RO - Romania 3
RS - Serbia 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CY - Cipro 2
GE - Georgia 2
KH - Cambogia 2
LK - Sri Lanka 2
MD - Moldavia 2
PS - Palestinian Territory 2
SN - Senegal 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
Totale 25.223
Città #
Southend 2.440
Ashburn 1.066
Fairfield 1.049
Woodbridge 1.046
Jacksonville 862
Houston 861
San Jose 742
Chandler 690
Singapore 662
Ann Arbor 659
Cambridge 473
Nanjing 460
Seattle 446
Wilmington 397
Dallas 364
Izmir 309
Beijing 271
Council Bluffs 263
Urbino 244
Boardman 234
Dublin 214
Helsinki 200
New York 175
Nanchang 168
Los Angeles 148
San Mateo 129
Princeton 125
Lauterbourg 116
Moscow 102
Shenyang 99
Jiaxing 86
Hebei 82
Tianjin 81
Düsseldorf 79
Santa Clara 79
Munich 72
Changsha 68
Ho Chi Minh City 68
Milan 61
Mülheim 56
Jinan 55
Shanghai 54
Kunming 51
San Diego 50
San Francisco 48
Istanbul 45
Ancona 43
Frankfurt am Main 43
Hanoi 43
Bremen 42
Buffalo 42
Rome 42
São Paulo 40
Hong Kong 39
Guangzhou 37
Orem 37
London 32
Toronto 31
Seongnam 30
Warsaw 30
Brussels 29
Hangzhou 28
Atlanta 27
Chicago 27
Denver 27
Velikiy Novgorod 27
Phoenix 25
Ningbo 24
Turku 24
Brooklyn 23
The Dalles 23
Tokyo 23
Chennai 22
Zhengzhou 22
Des Moines 20
Stockholm 20
Poplar 18
Taizhou 18
Boston 17
Amsterdam 16
Montreal 16
Bologna 15
Brasília 14
Dong Ket 14
Lanzhou 13
Mumbai 12
Rio de Janeiro 12
Naples 11
Quito 11
Turin 11
Auburn Hills 10
Fuzhou 10
Johannesburg 10
Melbourne 10
Perugia 10
Shenzhen 10
Bellaria-Igea Marina 9
Haikou 9
Mergo 9
Mexico City 9
Totale 17.265
Nome #
Targeting SARS-CoV-2 by synthetic dual-acting thiol compounds that inhibit Spike/ACE2 interaction and viral protein production 561
Glutathione Depletion Is Linked with Th2 Polarization in Mice with a Retrovirus-Induced Immunodeficiency Syndrome, Murine AIDS: Role of Proglutathione Molecules as Immunotherapeutics 440
In vitro effects on calcium oxalate crystallization kinetics and crystal morphology of an aqueous extract from Ceterach officinarum: analysis of a potential antilithiatic mechanism 345
Bacteria-produced ferric exopolysaccharide nanoparticles as iron delivery system for truffles (Tuber borchii) 321
Chitosan Nanoparticles for Topical Co-Administration of the Antioxidants Glutathione and Idebenone: Characterization and In Vitro Release 310
Design, synthesis and biological activity of hydrogen peroxide responsive arylboronate melatonin hybrids 306
Inhibition of murine AIDS by pro-glutathione (GSH) molecules 288
2',3'-Dideoxycytidine induced drug resistance in human cells 282
2',3'-Dideoxycytidine metabolism in a new drug-resistant cell line 276
A versatile vector system for generating recombinant EGFP-tagged proteins in yeast 270
Comparison of novel delivery systems for antisense peptide nucleic acids 268
Pharmacokinetic and antiretroviral activity in mice of oral [P(1),P(2)-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine 265
Characterization and complementation of a Fus3/Kss1 type MAPK from Tuber borchii, TBMK 260
2',3'-Dideoxycytidine induced drug-resistance in human cells 257
Drug delivery through phagocytosis of red blood cells 254
Erythrocyte-based drug delivery 253
Enhanced antisense effect of modified PNAs delivered through functional PMMA microspheres 243
Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model. 236
Inhibition of macrophage iNOS by selective targeting of antisense PNA. 235
Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5'-triphosphate 235
Antiretroviral effect of combined zidovudine and reduced glutathione therapy in murine AIDS. 233
A Dinuclear Copper(II) Complex as Nitric Oxide Trapper in a Stimulated Murine Macrophage Model 230
Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application 225
ATP modifications in hexokinase deficient fibroblasts exposed to nutrient shifts. 224
Glucose metabolism in fibroblasts from patients with erythrocyte hexokinase deficiency. 223
Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application 223
Development of a multilevel approach for the evaluation of nanomaterials toxicity 222
Cloning and expression of a new human polypeptide which regulates protein phosphorylation in Escherichia coli 221
Inhibition of murine AIDS by reduced glutathione. 220
New treatment protocol including lympholytic and antiretroviral drugs to inhibit murine AIDS 219
Repeated cycles of alternate administration of fludarabine and zidovudine plus didanosine inhibits murine AIDS and reduces proviral DNA content in lymph nodes to undetectable levels 217
Red blood cell phagocytosis and lysis following oxidative damage by phenylhydrazine. 216
Red blood cells as glucocorticoids delivery system. 212
Core-shell nanospheres for oligonucleotide delivery. V: adsorption/release behavior of 'stealth' nanospheres 211
Simultaneous extraction and HPLC determination of ATP, ADP, AMP, NADP+ NADPH, NAD+ and NADH in human red blood cells. 211
The use of Eudragit RS 100/cyclodextrin nanoparticles for the transmucosal administration of glutathione. 211
Heat stress-activated, calcium dependent nitric oxide synthase in sponges 210
Glucose 1,6-diphosphate in the erythrocytes of various species of mammal 208
Purification, properties, and evidence for two subtypes of human placenta hexokinase type I. 207
CYTOTOXICITY AND PROINFLAMMATORY ACTIVITY OF DIESEL AND BIO-DIESEL EXHAUST PARTICLE ON HUMAN KERATINOCYTES. 206
Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter 206
Simultaneous extraction and reverse-phase high-performance liquid chromatographic determination of adenine and pyridine nucleotides in human red blood cells 206
AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: homologous erythrocytes as a delivery system for preferential immunization with putative protective antigens 203
CYTOTOXICITY OF NANOPARTICLES 203
Dinuclear Copper (II) complex as nitric oxide scavenger in stimulated murine macrophage model 200
TOXICITY COMPARISON OF DIESEL EXHAUST PARTICLE (DEP) FROM AN URBAN BUS ENGINE FUELLED WITH DIESEL OIL AND 'BIODIESEL' BLEND. 197
Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides 195
Human erythrocytes phosphoglucomutase: comparison of the kinetic properties of PGM1 and PGM2 isoenzymes 193
Immunological quantification of human hexokinase type I 193
Human erythrocyte hexokinases are immunologically related 193
A New Dinuclear Copper(II) Complex to Trap Nitric Oxide 192
Red blood cell phagocytosis following hexokinase inactivation. 191
Inhibition of murine AIDS by combination of AZT and DDCTP-loaded erythrocytes 190
Esocinasi in fibroblasti umani. 187
Preparation and characterization of monoclonal antibodies to human hexokinase type I. 186
High production of secondary metabolites and biological activities of Cydonia oblonga Mill. pulp fruit callus 185
Inhibition of Murine AIDS by a New Azidothymidine Homodinucleotide. 185
Red blood cells as a glucocorticoids delivery system 185
Modulated red blood cell survival by membrane protein clustering 185
Targeting dexamethasone to macrophages. 184
Inhibition of murine AIDS by a new azidothymidine homodinucleotide 183
In vivo survival and in vitro phagocytosis of engineered erythrocytes. 182
Disparities in Cancer Incidence in Armenia, 2013-2016: Setting Priorities for Preventive Interventions. 181
Il glucoso 1,6 difosfato negli eritrociti di differenti specie di mammifero 180
Red blood cell mediated delivery of recombinant HIV-1 Tat protein in mice induces anti-Tat protein in mice induces anti-Tat neutralizing antibodies and CTL. 179
Metabolism, mitochondrial uptake and toxicity of 2’,3’-dideoxycytidine 178
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 178
Liposomes as carriers of the antiretroviral agent dideoxycytidine-5'-triphosphate. 178
Studi preliminari sull’effetto proinfiammatorio in cheratinociti umani della porzione idrosolubile del particolato atmosferico frazionato. 176
The interaction of phosphorylated sugars with human hexokinase I. 176
Bilancio di genere 2022 175
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: immunogenicity and protection in mice 175
Inhibition of murine AIDS by alternate administration of azidothimidine and fludarabine monofosfate. 172
Effetto dell'età sulla sopravvivenza degli eritrociti di topo. 171
Red blood cells as an antigen-delivery system. 170
Role of hexokinase in the regulation of glucose metabolism in human erythrocytes. 169
Immunological studies on mammalian hexokinase 169
Erythrocytes as carriers of reduced glutathione (GSH) in the treatment of retroviral infections 169
In vitro and in vivo toxicity of 2',3'-dideoxycytidine in mice 167
Vaccination strategy using red blood cells as antigen delivery system. 167
Immunological studies on mammalian hexokinase. 164
Use of fluorescent probes for describing the process of encapsulation by hypotonic dialysis. 162
In vitro evaluation of nanomaterials toxicity 162
Red blood cells as carriers of drugs against retroviruses 161
Molecular basis of the 2',3'-dideoxycytidine induced drug-resistance in human cells 160
Vie degradative del glucoso 1,6 difosfato negli eritrociti umani. 159
Antinsense peptide nucleic acid delivered by core-shell microspheres. 159
Cine CUG (2022-2023) 157
Role of macrophage protection in the development of murine AIDS. 157
Similarities and differences between human and rat hexokinases type I. 154
Molecular basis of 2',3'-dideoxycytidine-induced drug resistance in human cells. 154
New drug combinations for the treatment of murine AIDS and macrophage protection. 154
New delivery systems for antisense Peptide Nucleic Acids. 152
In vitro targeting of doxorubicin loaded canine erythrocytes to cytotoxic T-lymphocytes (CTLL). 151
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 151
Introduction to in vivo targeting. 151
Rabbit red blood cell hexokinase. Decay mechanism during reticulocyte maturation. 149
NUCLEIC ACIDS AND PROTEIN DELIVERY THROUGH POLYMERIC CORE-SHELL NANOSPHERES 148
Role of macrophage protection in the development of murine AIDS 145
Immobilization of enzymes and proteins on red blood cells. 143
Totale 20.701
Categoria #
all - tutte 89.186
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.186


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022920 0 0 0 191 40 46 56 73 82 65 23 344
2022/20232.475 235 104 40 225 194 456 7 152 537 137 277 111
2023/2024653 74 39 38 65 46 162 22 67 8 59 19 54
2024/20252.279 102 109 496 157 69 160 269 115 245 169 221 167
2025/20265.098 436 509 564 928 387 372 736 114 291 421 227 113
2026/20271.006 214 112 544 136 0 0 0 0 0 0 0 0
Totale 25.400